Unity Biotechnology, Inc. Accrued Employee Benefits, Current
Unity Biotechnology, Inc. had Accrued Employee Benefits, Current of $1.24 million as of 2025-03-31, per its 10-Q filed 2025-04-22.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedEmployeeBenefitsCurrent · last filed 2025-04-22
- 2025-03-31: Accrued Employee Benefits, Current $1.24M.
- 2024-12-31: Accrued Employee Benefits, Current $2.10M.
- 2024-09-30: Accrued Employee Benefits, Current $1.70M.
- 2024-06-30: Accrued Employee Benefits, Current $1.39M.
| Period end | Accrued Employee Benefits, Current |
|---|---|
| 2025-03-31 | $1.24M 10-Q · filed 2025-04-22 |
| 2024-12-31 | $2.10M 10-Q · filed 2025-04-22 |
| 2024-09-30 | $1.70M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $1.39M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $1.15M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.84M 10-K · filed 2025-03-07 |
| 2023-09-30 | $2.23M 10-K · filed 2024-04-15 |
| 2023-06-30 | $1.65M 10-K · filed 2024-04-15 |
| 2023-03-31 | $1.98M 10-K · filed 2024-04-15 |
| 2022-12-31 | $3.02M 10-K · filed 2024-04-15 |
| 2022-09-30 | $2.96M 10-K · filed 2024-04-15 |
| 2022-06-30 | $3.29M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $2.84M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $4.03M 10-K · filed 2023-03-15 |
| 2021-09-30 | $3.40M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $2.61M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $1.84M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $5.36M 10-K · filed 2022-03-15 |
| 2020-09-30 | $5.73M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $3.65M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $2.22M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $5.91M 10-K · filed 2021-03-23 |
| 2019-09-30 | $3.67M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $2.74M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $1.67M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $3.79M 10-K · filed 2020-03-11 |
| 2018-09-30 | $2.84M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $1.94M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $958.00K 10-Q · filed 2018-06-07 |
| 2017-12-31 | $2.18M 10-K · filed 2019-03-06 |